Items tagged with Access
Patna teen who fought to get TB care in Mumbai, dies (post)
The girl was brought to Mumbai in a state of being unable to breath and with an oxygen cylinder owing to scarring in her lungs. The extreme delay in treatment caused severe damage to her lungs, resulting in her death.
MPP and Unitaid publish intellectual property report on long-acting technologies (post)
The Medicines Patent Pool (MPP) and Unitaid have jointly published a study into the patent landscape for long-acting technologies with the potential to have a major impact on preventing or treating HIV, hepatitis C, tuberculosis, and malaria in low- and middle-income countries.
TAGline Fall 2018: Intellectual property and access (post)
Bringing down the House on intellectual property and access
The world needs a urine test for TB. But it’s already here. (post)
The W.H.O. has recommended such a test for H.I.V.-positive patients since 2015. But in poor countries, few qualifying patients are receiving it.
India: Lack of digital ECGs slows roll-out of anti-TB drug (post)
The roll-out of crucial anti-tuberculosis drug, Bedaquiline is slow because of a substantial lack of digital electrocardiogram (ECG) machines on field.
Sewri TB hospital starts giving bedaquiline to outpatients (post)
In an attempt to prioritise the comfort of patients suffering from tuberculosis, the civic-run TB hospital in Sewri has started giving bedaquiline in the outpatient department (OPD).
India: Delamanid to be available across the country (post)
Crucial anti-Tuberculosis (TB) drug Delamanid will now be available across India. Until currently, its supply was restricted to seven States.
As patients challenge patent, J&J commits to tackling drug-resistant TB (post)
Johnson & Johnson has tripled its commitment on tuberculosis drug Bedaquiline by offering 90,000 doseages to its global donation programme that ends in March, Paul Stoffels, J&J’s Vice-Chair of the Executive Committee and Chief Scientific Officer, said, on a programme that has given medicines to India as well.
India’s drug-resistant TB patients face delayed and confusing diagnoses, treatment (post)
Mumbai: Drug-resistant tuberculosis (DR-TB) patients in India face delayed diagnoses, different treatment pathways from both public and private health care systems and differing costs for the same treatments from different providers in an unregulated private health care sector, says a January 2019 study published in Public Library of Science (PLOS), a scientific journal.
UN approves five sanctions exemptions for humanitarian aid to North Korea (post)
Approval sees return of Médecins Sans Frontières (MSF) to North Korea after four-year absence.
Page 36 of 83 · Total posts: 0
←First 35 36 37 Last→